LL37 was produced by epithelial tissues, as well as the innate immune system, such as human neutrophils, monocytes/macrophages, lymphocytes, mast cells, etc.,45 and it was identified as a broad-spectrum antimicrobial factor and used to inhibit respiratory syncytial virus infection.46 Here, CAMP is linked to respiratory syncytial virus infectious disease.